Updated:
AquaBounty Technologies
AquaBounty Technologies is a publicly traded aquaculture firm using gene-editing to produce faster-growing salmon from land-based farms.
AquaBounty Technologies
AquaBounty Technologies operates as a biotechnology firm focused on aquaculture. Founded in the 1990s, the company develops genetically engineered Atlantic salmon that reach market weight faster than conventional fish. The underlying wealth stems from public markets rather than a private family fortune. The firm's strategy centers on land-based salmon farming using proprietary gene-editing technology. It targets the aquaculture sector with direct production of fish for commercial sale. Known investments include its own farm facility in Albany, Indiana, and research operations in Canada (per the firm's disclosures). The geographic footprint covers North America. AquaBounty remains a small public company without a disclosed professional headcount. It maintains one operational office in Harvard, Massachusetts, and a facility in Indiana. No adjacent philanthropic vehicles or club memberships are known. The firm's recent activity is unverifiable in public sources. A structural differentiator is AquaBounty's dual identity as a biotech developer and a fish producer—combining genetic research with commercial farming. This vertical integration is unusual in aquaculture, where most firms focus on either breeding or grow-out.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Harvard
Corporate office
Harvard, MA, United States
Principals
John Curtis
Media Contact
Sector focus
Frequently asked questions
Who controls investment decisions at AquaBounty?
As a public company, AquaBounty's investment decisions are overseen by its board of directors and CEO. No single family office or individual controls capital allocation (per SEC filings).
What does AquaBounty's technology do?
AquaBounty uses genetic modification to accelerate salmon growth. Its AquAdvantage Salmon reaches market weight in about 18 months instead of the typical three years (per FDA approvals).
Is AquaBounty a family office or a corporate entity?
AquaBounty is a publicly traded corporation, not a family office. It files with the SEC and has no disclosed single-family-backing.
What stages does AquaBounty invest in?
AquaBounty does not operate as an investment firm. It raises capital through public equity and debt markets to fund its own production and research (per SEC filings).
Where does AquaBounty operate?
The company has facilities in Harvard, Massachusetts, and Albany, Indiana, with research operations in Canada (per the firm's website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: